Weekly Update: New diabetes clinical trial (18 items)

New diabetes clinical trial: Food as Medicine for HIV and Diabetes Published on: August 30, 2021 at 07:00PM Conditions:   Diabetes Mellitus, Type 2;   HIV Infections Interventions:   Behavioral: MTM + ILI;   Behavioral: Standard MTM Sponsors:   University of North Carolina, Chapel Hill;   Community Servings;   Massachusetts General Hospital;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05026723?term=diabetes&sfpd_d=14 August 30, 2021 at 08:22PM via ClinicalTrials.gov New diabetes clinical trial: Glycemic Response in Adults With Diabetes Published on: August 30, 2021 at 07:00PM Condition:   Diabetes Mellitus, Type 2 Interventions:   Other: Oral nutrition supplement - control;   Other: Oral nutrition supplement - test Sponsor:   Nestlé Enrolling by invitation https://clinicaltrials.gov/ct2/show/NCT05026424?term=diabetes&sfpd_d=14 August 30, 2021 at 08:22PM via ClinicalTrials.gov New diabetes clinical trial: Self-Management of Type-2 Diabetes Using a Mobile Application Published on: August 30, 2021 at 07:00PM Condition:   Diabetes Mellitus Intervention:   Other: DiaMon - Mobile Application for Type 2 Diabetes mellitus and pre-diabetes Sponsor:   University of Mauritius Completed https://clinicaltrials.gov/ct2/show/NCT05027334?term=diabetes&sfpd_d=14 August 30, 2021 at 08:22PM via ClinicalTrials.gov New diabetes clinical trial: Randomized Controlled Trial of Digital Diabetes Self Management Education and Support for Patients With Type 2 Diabetes Published on: August 30, 2021 at 07:00PM Condition:   Type 2 Diabetes Intervention:   Other: Digital diabetes self management education and support system Sponsors:   Region Jönköping County;   Linkoeping University;   Region Östergötland;   Uppsala County Council, Sweden;   The Swedish Diabetes Foundation;   Medical Research Council of Southeast Sweden Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05026528?term=diabetes&sfpd_d=14 August 30, 2021 at 08:22PM via ClinicalTrials.gov New diabetes clinical trial: The Effect of SGLT-2 Inhibitor in Patient With Atrial Fibrillation and Diabetes Mellitus Published on: August 31, 2021 at 07:00PM Conditions:   SGLT-2 Inhibitor;   Atrial Fibrillation;   Diabetes Mellitus, Type 2 Intervention:   Drug: SGLT2 inhibitor Sponsor:   Ewha Womans University Mokdong Hospital Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05029115?term=diabetes&sfpd_d=14 August 31, 2021 at 05:22PM via ClinicalTrials.gov New diabetes clinical trial: InPen User Experience Published on: August 31, 2021 at 07:00PM Condition:   Diabetes Type 1 Intervention:   Device: InPen with Guardian 4 System Sponsor:   Medtronic Diabetes Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05029271?term=diabetes&sfpd_d=14 August 31, 2021 at 05:22PM via ClinicalTrials.gov New diabetes clinical trial: Clinical Outcomes From Enhanced SCREENing Strategies for Advanced NASH in Type 2 Diabetes (SCREEN NASH T2D) Published on: August 31, 2021 at 07:00PM Conditions:   Nonalcoholic Steatohepatitis;   Type 2 Diabetes Interventions:   Other: routine screening;   Other: physician-driven screening Sponsor:   LMC Diabetes & Endocrinology Ltd. Recruiting https://clinicaltrials.gov/ct2/show/NCT05029583?term=diabetes&sfpd_d=14 August 31, 2021 at 05:22PM via ClinicalTrials.gov New diabetes clinical trial: Efficacy and Safety of Piemonte Association in the Treatment of Type II Diabetes Mellitus Published on: August 31, 2021 at 07:00PM Condition:   Type II Diabetes Interventions:   Drug: PIEMONTE;   Other: PIEMONTE PLACEBO;   Drug: EMPAGLIFLOZIN;   Other: PLACEBO EMPAGLIFLOZIN;   Drug: PIOGLITAZONE;   Other: PLACEBO PIOGLITAZONE Sponsor:   EMS Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05028140?term=diabetes&sfpd_d=14 August 31, 2021 at 05:22PM via ClinicalTrials.gov New diabetes clinical trial: Blood Glucose Monitoring Systems: Discounter Versus Brand Published on: September 01, 2021 at 07:00PM Condition:   Diabetes Mellitus Interventions:   Diagnostic Test: blood glucose measurement: POCT;   Diagnostic Test: blood glucose measurement: reference Sponsor:   Institut fur Diabetes Karlsburg GmbH Enrolling by invitation https://clinicaltrials.gov/ct2/show/NCT05031000?term=diabetes&sfpd_d=14 September 01, 2021 at 05:29PM via ClinicalTrials.gov New diabetes clinical trial: Time Limited Eating in Type 1 Diabetes Published on: September 01, 2021 at 07:00PM Condition:   Type 1 Diabetes Intervention:   Other: Time Limited Eating Sponsor:   Children's Hospital Los Angeles Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05031429?term=diabetes&sfpd_d=14 September 01, 2021 at 05:29PM via ClinicalTrials.gov New diabetes clinical trial: Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes Published on: September 01, 2021 at 07:00PM Conditions:   Diabetes Mellitus, Type 2;   Exercise;   Walking Pneumonia;   Diabetes Intervention:   Other: Education Sponsor:   Ege University Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05029804?term=diabetes&sfpd_d=14 September 01, 2021 at 05:29PM via ClinicalTrials.gov New diabetes clinical trial: The Effect of IMB Model-Based Nursing Interventions on Care Outcomes in Adults With Type 2 Diabetes Published on: September 01, 2021 at 07:00PM Conditions:   Type2 Diabetes;   HbA1c;   BMI;   Self Efficacy;   Self Management Intervention:   Behavioral: Diabetes Education and Video Call-based Motivational Interviewing Sponsor:   Pamukkale University Recruiting https://clinicaltrials.gov/ct2/show/NCT05030844?term=diabetes&sfpd_d=14 September 01, 2021 at 05:29PM via ClinicalTrials.gov New diabetes clinical trial: Screening for Sacral Agenesis in Offspring of Mothers With Diabetes in Pregnancy Published on: September 02, 2021 at 07:00PM Conditions:   Infant of Diabetic Mother;   Sacral Agenesis Intervention:   Sponsor:   University of Missouri-Columbia Recruiting https://clinicaltrials.gov/ct2/show/NCT05033275?term=diabetes&sfpd_d=14 September 02, 2021 at 05:22PM via ClinicalTrials.gov New diabetes clinical trial: ORAL ANTIDIABETICS EFFECT ON VISCERAL FAT IN TYPE 2 DIABETES PATIENTS Published on: September 02, 2021 at 07:00PM Conditions:   Abdominal Obesity;   Type 2 Diabetes Intervention:   Drug: Biguanide, DPP4 inhibitors, SGLT2 inhibitors Sponsor:   Metabolic Research Unit Enrolling by invitation https://clinicaltrials.gov/ct2/show/NCT05032001?term=diabetes&sfpd_d=14 September 02, 2021 at 05:22PM via ClinicalTrials.gov New diabetes clinical trial: Ladarixin as Adjunctive Therapy to Improve Insulin Sensitivity and Glucometabolic Outcomes in Type 1 Diabetes Published on: September 06, 2021 at 07:00PM Condition:   Type I Diabetes Intervention:   Drug: Ladarixin Sponsor:   Dompé Farmaceutici S.p.A Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05035368?term=diabetes&sfpd_d=14 September 05, 2021 at 06:22PM via ClinicalTrials.gov New diabetes clinical trial: Comparison of the FGM Profiles in Patients of Type 2 Diabetes Treated With Sitagliptin and Acarbose Published on: September 06, 2021 at 07:00PM Condition:   Type 2 Diabetes Intervention:   Drug: sitagliptin and acarbose Sponsor:   Nanjing First Hospital, Nanjing Medical University Completed https://clinicaltrials.gov/ct2/show/NCT05035849?term=diabetes&sfpd_d=14 September 05, 2021 at 06:22PM via ClinicalTrials.gov New diabetes clinical trial: A Research Study Comparing RYBELSUS® to Other Blood Sugar Lowering Tablets in People Living in America With Type 2 Diabetes (REALYSE) Published on: September 03, 2021 at 07:00PM Condition:   Diabetes Mellitus, Type 2 Interventions:   Drug: semaglutide;   Drug: oral glucose-lowering medications (commercially available) Sponsor:   Novo Nordisk A/S Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05035082?term=diabetes&sfpd_d=14 September 05, 2021 at 06:22PM via ClinicalTrials.gov New diabetes clinical trial: A Study to Assess the Effect of Smart Insulin Pens on Glycemic Control and Diabetes-related Burdens Published on: September 06, 2021 at 07:00PM Condition:   Type 1 Diabetes Intervention:   Device: InPen® Sponsor:   Mayo Clinic Enrolling by invitation https://clinicaltrials.gov/ct2/show/NCT05036343?term=diabetes&sfpd_d=14 September 05, 2021 at 06:22PM via ClinicalTrials.gov